Overview
Sulodexide is a mixture of glycosaminoglycans (GAGs) composed of dermatan sulfate (DS) and fast moving heparin (FMH).
Indication
Sulodexide has been used clinically for the prophylaxis and treatment of vascular diseases with increased risk of thrombosis, including intermittent claudication, peripheral arterial occlusive disease and post-myocardial infarc-tion. Also investigated in the treatment of diabetic kidney disease and diabetic neuropathy. New anti-inflammatory properties have also extended its use in venous disease.
Associated Conditions
- Venous Leg Ulcer (VLU)
- Chronic Venous Ulcers
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/05/21 | Phase 3 | ENROLLING_BY_INVITATION | Xijing Hospital | ||
2022/12/16 | Not Applicable | Not yet recruiting | Chengdu University of Traditional Chinese Medicine | ||
2022/05/12 | Phase 3 | Completed | Centro Medico del Noroeste | ||
2022/02/23 | Phase 4 | Terminated | Pirogov Russian National Research Medical University | ||
2021/08/13 | Phase 3 | Recruiting | Value Outcomes Ltd. | ||
2020/07/23 | Phase 2 | Completed | Clinedem | ||
2020/02/06 | Phase 3 | Recruiting | Arianna Anticoagulazione Foundation | ||
2018/04/20 | Phase 4 | Withdrawn | |||
2017/12/12 | Phase 3 | UNKNOWN | Alfa Wassermann Tunisia | ||
2016/04/14 | Phase 2 | Completed | St Joseph University, Beirut, Lebanon |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| ATERINA 60 MG/2 ML SOLUCION INYECTABLE | Alfasigma España, S.L. | 82783 | SOLUCIÓN INYECTABLE | Medicamento Sujeto A Prescripción Médica | Commercialized |
| ATERINA 25 MG CÁPSULAS BLANDAS | Alfasigma Espana S.L. | 90202 | CÁPSULA BLANDA | Medicamento Sujeto A Prescripción Médica | Not Commercialized |
| ATERINA 15 mg CAPSULAS BLANDAS | Alfasigma España, S.L. | 55545 | CÁPSULA BLANDA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| DOVIDA 30 MG CAPSULAS BLANDAS | Meiji Pharma Spain S.A. | 78901 | CÁPSULA BLANDA | Medicamento Sujeto A Prescripción Médica | Not Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.